Gastroparesis Trial, Recruiting NCT07717541 Sponsor: Ohio State University Condition: Gastroparesis
Back to Gastroparesis

Gastroparesis Trial, Recruiting

NCT07717541
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are at least 18 years old
  • People who are able to give informed consent to participate
  • People who can speak and understand English
  • People who are able to attend online poetry workshops
  • People who are willing to share at least 3 poems with the study team at the end of the study
  • People who have access to a high-speed internet connection and a smartphone or computer
  • People who are willing to take part in group activities if placed in the facilitated workshop group
  • People who have at least moderate digestive discomfort, meaning at least one of the following symptoms at a moderate or worse level: nausea, vomiting, feeling full quickly when eating, or feeling uncomfortably full after meals (assessed using a specific questionnaire)
  • People who have at least moderate anxiety or depression, based on a specific scoring tool called the HADS questionnaire, with a score of 21 or higher indicating moderate anxiety or depression is required for eligibility (confirm with trial site)

Who may not be able to join:

  • People who are unable to speak English or take part in online sessions
  • People who are younger than 18 years old

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Subhankar CHAKRABORTY, MD, Ph.D., Ohio State University

Phone: 614-293-6255'

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Ohio State University
Registry
ClinicalTrials.gov
Start date
17 July 2026
Est. completion
16 July 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Change in Anxiety and Depression Symptoms; Change in Dyspepsia Symptoms

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov